Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

NCT06956144 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT06956144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Observational
Overall status
Recruiting
Start date
May 9, 2025
Completion date
September 30, 2026
Enrollment
113 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbonic anhydrase ix, tumor